Un estudio internacional con participación de la Universidad Autónoma de Madrid (UAM) ha vinculado una mayor ingesta de proteínas, tanto vegetales como animales, con una reducción en la mortalidad...
Read moreNew study shows the urgent need to use early diagnostic tools to accurately identify the cause of such symptoms and tailor interventions to reduce mortality in children
Read moreUn estudio pionero en España ha analizado las posibles causas genéticas de la enfermedad renal crónica idiopática, es decir, de origen desconocido.
Read moreOncoheroes Biosciences and Novartis have signed a worldwide, exclusive licensing agreement for dovitinib, a multi-tyrosine kinase inhibitor originally developed by Novartis. Under the terms of this ag...
Read moreEl objetivo es terminar de financiar el desarrollo de su fármaco LAM561 contra el cáncer cerebral más agresivo y común, el glioblastoma multiforme, cuyos pacientes hoy en día siguen recibiendo el...
Read moreDemuestran que el inhibidor selectivo de PARP1 saruparib (AZD5305) produce una respuesta antitumoral más potente y duradera que olaparib, un inhibidor de primera generación actualmente aprobado para...
Read moreSpadaHC permite a los laboratorios contribuir tanto con clasificaciones de variantes genéticas como con las variantes de individuos en formato VCF (Variant Call Format), que es utilizado para almacen...
Read moreResearchers at the Centre for Genomic Regulation (CRG) have discovered hundreds of potential new cancer driver genes. The findings, published in the journal Nature Communications, significantly expand...
Read moreThe international IciStem consortium, co-coordinated by IrsiCaixa, confirms the sixth person to achieve HIV remission after a stem cell transplant. Thirty-two months after stopping antiretroviral ther...
Read moreIt has been concluded that there is a clearly direct and significant relationship between the intensity of changes in emotional state due to stress factors during the COVID-19 pandemic lockdown and th...
Read moreOryzon Genomics, S.A. announced today that it has received additional “Decision to grant” communications for important patents relating vafidemstat, Oryzon’s LSD1 inhibitor in clinical developme...
Read moreCoordinated by Alfonso Martínez Arias, from the Department of Medicine and Life Sciences at UPF, experts in different aspects of stem cell and developmental biology propose criteria required for the ...
Read more